These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 9209906)

  • 1. Optimizing chemotherapy and radiotherapy in locally advanced non-small cell lung cancer.
    Arriagada R
    Hematol Oncol Clin North Am; 1997 Jun; 11(3):461-72. PubMed ID: 9209906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scheduling of chemotherapy and radiotherapy in locally advanced non-small cell lung cancer.
    Bishop JF
    Lung Cancer; 1995 Jun; 12 Suppl 2():S53-61. PubMed ID: 7551950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-surgical therapy for patients with advanced non-small cell lung cancer.
    Clarke SJ; Boyer MJ
    Respirology; 1998 Sep; 3(3):175-82. PubMed ID: 9767616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
    Segawa Y; Ueoka H; Kiura K; Kamei H; Tabata M; Sakae K; Hiraki Y; Kawahara S; Eguchi K; Hiraki S; Harada M
    Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined modality therapy of non-small cell lung cancers.
    Juretic A; Sobat H; Samija M
    Ann Oncol; 1999; 10 Suppl 6():93-8. PubMed ID: 10676559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Standards, options and recommendations for the management of locally advanced non small cell lung carcinoma].
    Bardet E; Moro-Sibilot D; Le Chevalier T; Massard G; Douillard JY; Theobald S; Astoul P; Baldeyrou P; Bazelly B; Bréchot J; Breton JL; Grivaux P; Jacoulet P; Khalil A; Lemarie E; Martinet Y; Milleron B; Paesmans M; Pujol JL; Quoix AE; Ranfaing E; Rivière A; Sancho-Garnier H; Souquet PJ; Spaeth D; Stcebner-Delbarre A; Thiberville L; Touboul E; Vaylet F; Vergnon JM; Westeel V; Depierre A; Lagrange JL
    Bull Cancer; 2001 Apr; 88(4):369-87. PubMed ID: 11371371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent cetuximab and radiotherapy after docetaxel-cisplatin induction chemotherapy in stage III NSCLC: satellite--a phase II study from the Swedish Lung Cancer Study Group.
    Hallqvist A; Wagenius G; Rylander H; Brodin O; Holmberg E; Lödén B; Ewers SB; Bergström S; Wichardt-Johansson G; Nilsson K; Ekberg L; Sederholm C; Nyman J
    Lung Cancer; 2011 Feb; 71(2):166-72. PubMed ID: 20541833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non-small-cell lung cancer (NSCLC) and an increased risk of treatment complications. Preliminary results.
    Semrau S; Bier A; Thierbach U; Virchow C; Ketterer P; Fietkau R
    Strahlenther Onkol; 2003 Dec; 179(12):823-31. PubMed ID: 14652671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
    Okawara G; Rusthoven J; Newman T; Findlay B; Evans W
    Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing chemoradiation therapy approaches to unresectable stage III non--small cell lung cancer.
    Gaspar LE
    Curr Opin Oncol; 2001 Mar; 13(2):110-5. PubMed ID: 11224708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NSCLC: primary tumor size--radiation dose-related accelerated, twice daily radiotherapy by target splitting, preceded by 2 cycles of chemotherapy--first results of a prospective study.
    Wurstbauer K; Deutschmann H; Kopp P; Kranzinger M; Merz F; Nairz O; Studnicka M; Sedlmayer F
    Strahlenther Onkol; 2007 Dec; 183 Spec No 2():38-40. PubMed ID: 18167008
    [No Abstract]   [Full Text] [Related]  

  • 12. Benefits and adverse events among elderly patients receiving concurrent chemoradiotherapy for locally advanced non-small cell lung cancer: analysis of the Okayama Lung Cancer Study Group trial 0007.
    Takigawa N; Kiura K; Segawa Y; Hotta K; Tamaoki A; Tokuda Y; Nagata T; Watanabe K; Gemba K; Moritaka T; Horita N; Takeda H; Okimoto N; Takemoto M; Matsuo K; Shinkai T; Tabata M; Ueoka H; Kanazawa S; Tanimoto M
    J Thorac Oncol; 2011 Jun; 6(6):1087-91. PubMed ID: 21415777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of three-dimensional conformal radiotherapy and concurrent mitomycin-C, vinblastine, and cisplatin chemotherapy for Stage III locally advanced, unresectable, non-small-cell lung cancer.
    Lee SW; Choi EK; Lee JS; Lee SD; Suh C; Kim SW; Kim WS; Ahn SD; Yi BY; Kim JH; Noh YJ; Kim SS; Koh Y; Kim DS; Kim WD
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):996-1004. PubMed ID: 12829135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phase III studies of combined chemotherapy and radiation in locally advanced non-small-cell lung cancer and limited small-cell lung cancer].
    Kawahara M
    Gan To Kagaku Ryoho; 1995 Feb; 22(3):335-40. PubMed ID: 7880104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Does chemotherapy improve the results of postoperative radiotherapy in completely resected stage II and IIIA non-small-cell bronchial cancer?].
    Baumann M
    Strahlenther Onkol; 2001 Apr; 177(4):220-1. PubMed ID: 11370558
    [No Abstract]   [Full Text] [Related]  

  • 16. Concurrent low-dose cisplatin and thoracic radiotherapy in patients with inoperable stage III non-small cell lung cancer: a phase II trial with special reference to the hemoglobin level as prognostic parameter.
    Pradier O; Lederer K; Hille A; Weiss E; Christiansen H; Schmidberger H; Hess CF
    J Cancer Res Clin Oncol; 2005 Apr; 131(4):261-9. PubMed ID: 15616830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of inoperable non-small cell lung cancer: induction chemotherapy or hyperfractionated radiotherapy? Apropos of 2 recent therapeutic trials].
    Reboul F; Vincent P; Chauvet B; Brewer Y; Taulelle M
    Cancer Radiother; 1998; 2(3):287-9. PubMed ID: 9749128
    [No Abstract]   [Full Text] [Related]  

  • 18. Evolution and future perspectives in the treatment of locally advanced non-small cell lung cancer.
    Toschi L; Cappuzzo F; Jänne PA
    Ann Oncol; 2007 Jul; 18 Suppl 9():ix150-5. PubMed ID: 17631569
    [No Abstract]   [Full Text] [Related]  

  • 19. Neoadjuvant etoposide, ifosfamide, and cisplatin followed by concomitant thoracic radiotherapy and continuous cisplatin infusion in stage IIIb non-small cell lung cancer.
    Pujol JL; Lafontaine T; Quantin X; Reme-Saumon M; Cupissol D; Khial F; Michel FB
    Chest; 1999 Jan; 115(1):144-50. PubMed ID: 9925076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined-modality treatment of locally advanced non-small cell lung cancer: incorporation of novel chemotherapeutic agents.
    Belani CP; Ramanathan RK
    Chest; 1998 Jan; 113(1 Suppl):53S-60S. PubMed ID: 9438691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.